Free Trial

Liquidia Technologies (LQDA) Competitors

Liquidia Technologies logo
$12.78 +0.33 (+2.65%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$12.71 -0.07 (-0.56%)
As of 07/8/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LQDA vs. TMDX, BLCO, SLNO, INSP, NVST, PRCT, LIVN, WRBY, NVCR, and LMAT

Should you be buying Liquidia Technologies stock or one of its competitors? The main competitors of Liquidia Technologies include TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), Warby Parker (WRBY), NovoCure (NVCR), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry.

Liquidia Technologies vs. Its Competitors

TransMedics Group (NASDAQ:TMDX) and Liquidia Technologies (NASDAQ:LQDA) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk.

TransMedics Group has higher revenue and earnings than Liquidia Technologies. Liquidia Technologies is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TransMedics Group$441.54M9.55$35.46M$1.3691.71
Liquidia Technologies$14M78.04-$130.39M-$1.58-8.09

In the previous week, TransMedics Group had 4 more articles in the media than Liquidia Technologies. MarketBeat recorded 8 mentions for TransMedics Group and 4 mentions for Liquidia Technologies. TransMedics Group's average media sentiment score of 0.85 beat Liquidia Technologies' score of 0.31 indicating that TransMedics Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TransMedics Group
4 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Liquidia Technologies
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

TransMedics Group has a net margin of 10.03% compared to Liquidia Technologies' net margin of -903.80%. TransMedics Group's return on equity of 21.88% beat Liquidia Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
TransMedics Group10.03% 21.88% 6.15%
Liquidia Technologies -903.80%-177.91%-60.15%

TransMedics Group currently has a consensus target price of $127.33, indicating a potential upside of 2.09%. Liquidia Technologies has a consensus target price of $26.89, indicating a potential upside of 110.40%. Given Liquidia Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Liquidia Technologies is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TransMedics Group
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.80
Liquidia Technologies
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.00

99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 64.5% of Liquidia Technologies shares are held by institutional investors. 7.0% of TransMedics Group shares are held by company insiders. Comparatively, 30.1% of Liquidia Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

TransMedics Group has a beta of 2.06, meaning that its share price is 106% more volatile than the S&P 500. Comparatively, Liquidia Technologies has a beta of -0.01, meaning that its share price is 101% less volatile than the S&P 500.

Summary

TransMedics Group beats Liquidia Technologies on 11 of the 16 factors compared between the two stocks.

Get Liquidia Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LQDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LQDA vs. The Competition

MetricLiquidia TechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.06B$2.88B$5.47B$8.95B
Dividend YieldN/A2.46%5.25%4.06%
P/E Ratio-8.0920.8027.0020.10
Price / Sales78.04286.98435.75120.29
Price / CashN/A41.1936.8257.86
Price / Book14.047.487.985.56
Net Income-$130.39M-$55.04M$3.16B$248.40M
7 Day Performance5.97%5.44%3.69%6.04%
1 Month Performance-29.08%2.38%2.91%7.69%
1 Year Performance1.19%5.53%34.30%20.97%

Liquidia Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LQDA
Liquidia Technologies
3.182 of 5 stars
$12.78
+2.7%
$26.89
+110.4%
+2.7%$1.06B$14M-8.0950High Trading Volume
TMDX
TransMedics Group
1.5222 of 5 stars
$134.01
+1.9%
$127.33
-5.0%
-16.4%$4.45B$441.54M98.54210
BLCO
Bausch + Lomb
3.1036 of 5 stars
$13.03
+5.1%
$15.54
+19.3%
-8.2%$4.39B$4.79B-12.6513,500Analyst Forecast
High Trading Volume
SLNO
Soleno Therapeutics
4.7235 of 5 stars
$83.78
+0.6%
$107.10
+27.8%
+101.0%$4.20BN/A-18.1330
INSP
Inspire Medical Systems
4.8272 of 5 stars
$129.28
-2.4%
$211.91
+63.9%
-1.7%$3.91B$802.80M59.581,246News Coverage
Positive News
NVST
Envista
3.8065 of 5 stars
$19.58
-0.5%
$20.23
+3.3%
+22.8%$3.33B$2.51B-3.0012,300
PRCT
PROCEPT BioRobotics
2.6605 of 5 stars
$57.60
+1.2%
$90.00
+56.3%
-9.8%$3.15B$224.50M-33.88430News Coverage
Analyst Forecast
LIVN
LivaNova
3.2024 of 5 stars
$45.02
-1.6%
$59.29
+31.7%
-9.6%$2.49B$1.25B-11.012,900Positive News
WRBY
Warby Parker
1.9504 of 5 stars
$21.94
+0.2%
$22.88
+4.3%
+45.0%$2.29B$771.32M-182.833,780
NVCR
NovoCure
3.5767 of 5 stars
$17.80
-1.1%
$32.83
+84.5%
+9.4%$2.01B$605.22M-11.791,488Analyst Forecast
LMAT
LeMaitre Vascular
1.884 of 5 stars
$83.05
+0.6%
$97.83
+17.8%
+1.3%$1.87B$219.86M41.94490

Related Companies and Tools


This page (NASDAQ:LQDA) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners